In Race for Monkeypox Vaccines, experts see COVID rehearsal

In Race for Monkeypox Vaccines, experts see COVID rehearsal

In Race for Monkeypox Vaccines, experts see COVID rehearsal

The movements of rich countries to buy large amounts of monkeypox vaccine, while the decrease in sharing dose with Africa, could leave millions of people unprotected against a more dangerous version of the disease and continuous risk spills of the virus in humans, officials public health warning.

Critics fear a repetition of the catastrophic problems of inequality observed during the coronavirus pandemic.

“The mistakes we saw during the Covid-19 pandemic are already repeated,” said Dr. Boghuma Kabisen Titanji, a medical assistant professor at the University of Emory.

While rich countries have ordered millions of vaccines to stop Monkeypox on their border, no one announced plans to share doses with Africa, where the Monkeypox form is more deadly spreading than in the West.

Until now, there are more than 21,000 cases of Monkeypox reported in nearly 80 countries since May, with around 75 alleged deaths in Africa, most of them in Nigeria and Congo. On Friday, Brazil and Spain reported deaths related to Monkeypox, which was first reported outside of Africa.

Titanji said, “African countries that deal with the Monkeypox outbreak for decades have been reduced to footnotes in conversations about global responses”.

Scientists say that it is not like a campaign to stop Covid-19, mass vaccination against Monkeypox will not be needed. They think the use of available doses, along with other steps, can close the newly developing epidemic recently determined by the world health organization as a global emergency.

But while Monkeypox is far more difficult to spread than Covid-19, experts warn that if this disease extends to the general population-now in Europe and North America, it circulates almost exclusively among gay men and bisexuals-the need for vaccines can increase, especially if the virus becomes embedded in new areas.

On Thursday, the centers for the control and prevention of diseases in Africa asked that the continent be a priority for vaccines, saying that it was again left behind.

“If we are not safe, the rest of the world is not sure,” said the acting director of the CDC of Africa, Ahmed Ogwell.

Although it has been endemic in certain parts of Africa for decades, Monkeypox jumps mainly in people from infected wild animals and has generally not propelled very far beyond the continent.

Experts suspect the monkeypox outbreak in North America and Europe may come from Africa long before the disease began to spread through sex in two raves in Spain and Belgium. At present, more than 70% of the world’s monkeypox cases are in Europe, and 98% of cases are men who have sex with men.

W.H.O is developing a mechanism for the distribution of vaccines for affected countries but has released several details about how it works. The US health agency does not make a guarantee about prioritizing poor countries in Africa, only by saying that vaccines will be given based on epidemiological needs.

Some experts are worried that this mechanism can duplicate the problems that are seen with COVAX, created by W.H.O and partners in 2020 to try to ensure the poorer countries will get Covid-19 shots. Repeated targets that are missed to share vaccines with countries that are poorer and sometimes rely on donations.

“The simple fact of asking the countries to share will not be enough,” said Sharmila Shetty, a vaccines adviser for Medecins Sans Frontieres. “The more the monkeypox circulates, the more the chances to be able to enter new tanks of animals or spread” to the general human population, “she said. “If this happens, vaccination needs could change considerably.”

At present, there is only one of the most sophisticated Monkeypox vaccine producers: Denmark Bavarian Nordic Company. This year’s production capacity is around 30 million doses, with around 16 million vaccines available now.

In May, Bavarian Nordic asked the United States to disclose more than 215,000 doses it was to receive, “to help with the international requests that the company received” and the United States complied, according to Bill Hall, Spokesperson for the Ministry of Health and Human Services. The United States will always receive doses but on a later date.

The company refused to specify the countries for which it allocated the doses.

Hall said the United States had made no other promise to share vaccines. The United States has ordered the largest number of doses by far, with 13 million people reserved, although only about 1.4 million were delivered.

In Race for Monkeypox Vaccines, experts see COVID rehearsal